Almac Receives NY Lab Permit for Trial Enrichment and Companion Diagnostics Development
Almac's diagnostics business unit announced it has received a Clinical Laboratory Permit from the New York State Department of Health
Almac's diagnostics business unit announced it has received a Clinical Laboratory Permit from the New York State Department of Health, allowing Almac's Craigavon, UK-based lab to receive patient samples for clinical testing from New York. Almac has also successfully retained its CAP and CLIA accreditation following an inspection by the College of American Pathologists (CAP).
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025